Global Therapeutic Drug Monitoring Sales Market Report 2022

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.
Market Analysis and Insights: Global Therapeutic Drug Monitoring Market
Due to the COVID-19 pandemic, the global Therapeutic Drug Monitoring market size is estimated to be worth US$ 1710.7 million in 2021 and is forecast to a readjusted size of US$ 1710.7 million by 2028 with a CAGR of 6.1% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Therapeutic Drug Monitoring global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Roche, Danaher and Abbott are the major companies in the industry, accounting for 17.17%, 10.36% and 8.29% of the revenue respectively in 2019. By region, North America had the highest share of income, reaching 42.31 percent in 2019.
Global Therapeutic Drug Monitoring Scope and Market Size
The global Therapeutic Drug Monitoring market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Therapeutic Drug Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Blood Test
Urine Test
Saliva Test
Other Test
Segment by Application
Hospital Labs
Private Labs
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Sanquin
Becton Dickinson
Quest Diagnostics

Frequently Asked Questions